Turning Discovery Into Social Good

5:00 pm

Armstrong Medical Education Building

Case Study Room 402

Ten million people die needlessly every year of curable diseases simply because they cannot afford the life-saving medications that they need.  Johns Hopkins University, one of the largest recipients of NIH research funding, is a place where ground-breaking discoveries are made and developed into life-saving drugs, vaccines, and medical devices.  But do these life-saving technologies actually reach people who need them?  Can we do more to deliver Johns Hopkins discoveries to developing countries and the poor?  Join Rachel Kiddell-Monroe, President of the Universities Allied for Essential Medicines (UAEM) Board of Directors, as she discusses how universities can manage and trade their discoveries to have the greatest impact on global health.  Rachel, a member of the United Kingdom Law Society since 1991, has served as head of emergency humanitarian missions for Médecins San Frontieres (MSF) in Rwanda and Democratic Republic of Congo. She has also headed missions in Djibouti and Latin America. In 2003, Rachel led MSF’s Access to Medicines campaign in Canada. She is respected for her groundbreaking work to allow export of generic versions of brand name drugs to developing countries under the 2003 World Trade Organization patent waiver.

Hosted by Universities Allied for Essential Medicines